Compounded Semaglutide Dosing Errors: What the FDA Safety Alert Says

Compounded semaglutide typically ships as a multi-dose vial you draw up yourself with a syringe — a meaningfully different (and less forgiving) format than the preset, single-dose pens that come with FDA-approved Wegovy and Ozempic. The FDA has now formally flagged what that difference costs in real dosing errors, and it is worth understanding exactly what goes wrong before your first injection, not after.

What the FDA actually said

The FDA issued a direct alert to health care providers, compounders, and patients: "FDA has received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products"¹. The agency was specific about the mechanism, not vague about it: "Dosing errors have resulted from patients measuring and self-administering incorrect doses of the drug and health care providers miscalculating doses of the drug. Many of the patients who received vials of compounded semaglutide lacked experience with self-injections... unfamiliarity with withdrawing medication from a vial into a syringe... coupled with confusion between different units of measurement (e.g., milliliters, milligrams and 'units') may have contributed to dosing errors"¹. A peer-reviewed case series published in the *Journal of the American Pharmacists Association* independently documented the same pattern through calls to a regional poison control center — real administration errors, not a hypothetical risk².

Why compounded vials are riskier to measure than approved pens

FDA-approved semaglutide products (Wegovy, Ozempic) ship as pre-filled pens that deliver a preset dose — you dial or click to a number the pen enforces mechanically; there is no unit math for the patient to get wrong¹. Compounded semaglutide is different by construction: it typically arrives as a multi-dose vial, at a concentration that varies by compounder — and a single compounder may offer multiple different concentrations¹. That means the same nominal dose can correspond to a different volume depending on which vial you have, and the burden of getting the math right — converting a prescribed dose in milligrams into the correct volume in milliliters, drawn to the correct mark on an insulin syringe — falls on the patient, often someone self-injecting for the very first time.

The three things that actually cause the errors

Based on the FDA's own account, the errors cluster around three specific points of confusion, not general carelessness: unit confusion (mL vs. mg vs. "units" on an insulin syringe are three different scales, and mixing them up produces a dose that's off by a large factor, not a small one); concentration mismatches (assuming your vial matches a concentration you saw elsewhere — a chart, a forum post, a friend's vial — rather than the concentration actually printed on your own vial's label); and syringe mismatch (using the wrong syringe size for the intended dose, which makes fine measurement harder)¹.

How to actually avoid this

Confirm your vial's concentration in writing before your first dose, and never assume it matches what you have seen quoted elsewhere. Ask your provider or pharmacy for the exact syringe size intended for your dose, and have them walk you through drawing up the first dose live, not just via a written insert. Never eyeball a conversion between mg, mL, and "units" — get the specific number worked out for your specific vial, in writing, before you inject. If you have any doubt about a dose you have already drawn up, do not guess; contact your provider or a poison control center before injecting. Our dose calculator converts a prescribed milligram dose into syringe units at a given concentration — a useful cross-check, though it does not replace direct confirmation from your own provider about your own vial.

What this means for choosing a provider

This is a real, quantifiable reason prescriber support has to extend past the point of sale. A provider that ships a vial with a printed insert and nothing else has handed you the exact failure mode the FDA is warning about; one that actively walks new patients through drawing up their first dose has removed it. This is why member support and prescriber access are scored factors in our Verdict Score methodology — not soft, feel-good categories, but a real predictor of whether a patient ends up in this FDA alert's numerator. It is also one more reason to vet the pharmacy itself, which we cover fully in is compounded semaglutide legit and safe. Compare providers on real supported access in the ranked reviews.

Brand-name pens come prefilled at a fixed dose, which removes the drawing-up step: Sesame Care and Ro both offer brand-name Wegovy and Zepbound. If you stay on compounded vials, compare how providers price and support them on our semaglutide rankings.

This is editorial information, not medical advice. If you are unsure about a dose, contact your provider or a poison control center before administering it.

A unit conversion cannot validate a product or a treatment schedule. Follow the pharmacy verification checklist for the supplier and read the microdosing evidence review before interpreting a seller’s low-dose claims.